New drug delivery mechanisms, diagnostic and screening devices, clinical practice tools, and assistive technologies for allied health and rehabilitation are among more than 35 cutting edge medical innovations that leading university research commercialisation company UniQuest will be promoting at AusMedtech 2012 this week.
AusMedtech 2012 is Australia’s premier medical technology conference for more than 300 key stakeholders in the Australian and international medical devices and diagnostics sector. Held over two days (14-15 May) at the Four Seasons Hotel in Sydney, the Ausbiotech-run event includes an Investment Summit and Trade Exhibition.
UniQuest Managing Director, David Henderson, said the company would be sending conference delegates and hosting a Trade Exhibition booth.
“AusMedtech provides excellent opportunities for us to connect with potential commercial partners and investors whilst showcasing the exciting innovations being developed at the universities we represent,” Mr Henderson said.
“Australian university researchers are addressing global health issues, such as quality care access, aging populations, and preventable diseases, which are hot topics for investors and global companies looking to help launch the next blockbuster medical innovation.
“UniQuest’s medical technology portfolio includes innovations from The University of Queensland, University of Technology, Sydney, University of Wollongong, Mater Medical Research Institute, James Cook University, University of Tasmania, and Queensland Health, and this single point of access to such a scale of research resources helps to boost the capability profile of all our partner institutions,” he said.
The global medical technology market is one of the fastest growing markets in the world, currently valued at US$300 billion a year. UniQuest-licensed innovations are now generating annual sales of more than A$3 billion globally, from vaccines such as Gardasil to high-tech MRI machines and telehealth systems.
Media enquiries
For all media enquiries, contact our Marketing and Communications team.